Quartz Partners LLC Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Quartz Partners LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 482 shares of the healthcare conglomerate’s stock after buying an additional 50 shares during the period. Quartz Partners LLC’s holdings in UnitedHealth Group were worth $244,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Edge Capital Group LLC grew its stake in UnitedHealth Group by 7.4% in the 4th quarter. Edge Capital Group LLC now owns 2,700 shares of the healthcare conglomerate’s stock valued at $1,366,000 after acquiring an additional 185 shares during the period. Rothschild Investment LLC grew its position in shares of UnitedHealth Group by 2.3% in the fourth quarter. Rothschild Investment LLC now owns 6,399 shares of the healthcare conglomerate’s stock valued at $3,237,000 after purchasing an additional 146 shares during the period. Holistic Financial Partners raised its position in shares of UnitedHealth Group by 16.8% during the 4th quarter. Holistic Financial Partners now owns 1,035 shares of the healthcare conglomerate’s stock worth $524,000 after purchasing an additional 149 shares during the last quarter. Wealthstream Advisors Inc. boosted its holdings in UnitedHealth Group by 7.1% in the 4th quarter. Wealthstream Advisors Inc. now owns 1,939 shares of the healthcare conglomerate’s stock worth $981,000 after buying an additional 129 shares during the last quarter. Finally, Crestwood Advisors Group LLC raised its holdings in shares of UnitedHealth Group by 6.9% during the fourth quarter. Crestwood Advisors Group LLC now owns 4,147 shares of the healthcare conglomerate’s stock valued at $2,098,000 after acquiring an additional 269 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. KeyCorp reiterated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Performance

NYSE UNH opened at $465.58 on Monday. The stock has a 50-day moving average of $519.27 and a two-hundred day moving average of $560.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market cap of $428.46 billion, a P/E ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business earned $5.83 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.